Schedule III Compliance for Medical Cannabis Operators
Equipment and documentation planning for medical-cannabis operators preparing for the evolving Schedule III framework. Early adopters of pharmaceutical-grade infrastructure may be better positioned as the regulatory landscape evolves.
The DEA's April 28, 2026 final rule created a more defined federal controlled-substance framework for qualifying medical marijuana activity. Applicable registration, recordkeeping, reporting, security, labeling, and documentation requirements depend on an operator's specific product, activity, and jurisdiction.
The rule may create important planning considerations for qualifying operators. Prodigy helps customers scope equipment and documentation around their particular process and quality objectives.
Common Applications
Applicable Standards & Project Considerations
Meets or exceeds FDA 21 CFR manufacturing standards
Hazardous location electrical — required for hydrocarbon extraction
Pharmaceutical-grade fabrication standard
Equipment qualification for DEA compliance documentation
Canadian Registration Number for multi-market operators
Manufactured in Ohio by Mitchell Fabricators
Recommended Systems
Schedule a Schedule III Compliance Consultation
Talk to a Prodigy engineer about your specific application and compliance requirements.
Request a ConsultationOther Industries
Ready to Get Started?
Contact our engineering team to discuss your application, throughput requirements, and compliance pathway.